XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Operating activities          
Net income (loss) $ 2,628 $ 8,120 $ 2,914 $ (1,735)  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization     14,558 13,470  
Profit on sale of property, plant and equipment     (152) (73)  
Provision for doubtful accounts     (136) 32  
Amortization of debt issuance costs (including loss on extinguishment of debt)     286 11,302  
Amortization of call option premium     720 480  
Warrant contra revenue (0) 405 (0) 830  
Share-based compensation expense     833 591  
Deferred income taxes     (1,157) (1,255)  
Share of income of equity-accounted investees (3,833) (59) (3,825) (45)  
Changes in operating assets and liabilities:          
Trade accounts receivables     19,544 (11,412)  
Prepaid expenses and other assets     (25,539) (2,971)  
Trade accounts payable     (712) (9,965)  
Income taxes, net     (1,046) 2,724  
Accrued expenses and other liabilities     2,418 9,505  
Net cash provided by operating activities     8,706 11,478  
Investing activities          
Purchase of property, plant and equipment, net     (6,191) (7,513)  
Investment in equity-accounted investees     0 (25,000)  
Payments for call option premium     0 (3,000)  
Proceeds from equity-accounted investees     0 104  
Net cash used in investing activities     (6,191) (35,409)  
Financing activities          
Proceeds from the issuance of common stock     246 1,283  
Proceeds from long term debt (net of debt issuance cost paid to lenders)     0 156,525  
Payments of long term debt     0 (117,600)  
Payments for loan fees related to long term debt     0 (2,794)  
Proceeds from a line of credit, net     1,423 0  
Payments of other borrowings, net     (969) (9,431)  
Common stock repurchases     (1,334) 0  
Net cash (used in)/ provided by financing activities     (634) 27,983  
Net increase in cash and cash equivalents     1,881 4,052  
Effect of exchange rate changes on cash and cash equivalents and restricted cash     (1,486) (548)  
Cash and cash equivalents and restricted cash at beginning of period     55,396 50,559 $ 50,559
Cash and cash equivalents and restricted cash at end of period 55,791 54,063 55,791 54,063 55,396
Components of cash and cash equivalents and restricted cash          
Balances with banks 47,145 47,018 47,145 47,018 $ 47,940
Restricted cash 8,646 7,045 8,646 7,045  
Total cash and cash equivalents and restricted cash $ 55,791 $ 54,063 55,791 54,063  
Non-cash warrant contra revenue     0 830  
Non-cash share-based compensation expenses     833 591  
Supplemental disclosure of cash flow information          
Cash paid for interest and other finance cost     4,700 17,091  
Cash paid for income taxes     $ 5,573 $ 5,541